You are here

AusPAR: Lorlatinib

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

6 March 2020
AusPAR Details
AusPAR
Active Ingredient
Lorlatinib
Product Name
Lorviqua
Sponsor
Pfizer Australia Pty Ltd
Submission Number
PM-2018-04291-1-4
Submission Type
New chemical entity
Decision
Approved for provisional registration
AusPAR Date
21 February 2020
Publication Date

6 March 2020